ReviewJournal of food and drug analysis2019

Risk of adverse cardiovascular events with use of inhaled long-acting bronchodilators in management of chronic obstructive pulmonary disease.

Meng-Ting Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.